Kip 25

The Kiplinger 25: How We Did in a Very Contrary Year

Also, we move to rebalance our stock portfolio with a midcap offering.

In most gardens, some plants are in full bloom, while others wither. Same with investing: Stocks may zig, for example, as bonds zag. Last year, U.S. stocks zigged up … then down, then up again. Over the 12-month stretch ending March 15, Standard & Poor’s 500-stock index returned 4.8%.

But foreign markets couldn’t hold up under the weight of a stronger dollar, trade tensions and slowing global growth. The MSCI EAFE index, which tracks foreign stocks in developed countries, fell 5.0% over the past year. Rising interest rates pressured the bond market for much of 2018, but a late-year rally into early 2019 lifted Bloomberg Barclays U.S. Aggregate Bond index to a 3.7% one-year return.

How the Kip 25 performed

Six of our 12 U.S. diversified stock funds beat the S&P 500. Mairs & Power Growth (MPGFX), which had been in a funk, returned 8.9%. Two T. Rowe Price funds with different strategies finished well, too. Dividend Growth (PRDGX) gained 8.8%, and Blue Chip Growth (TRBCX) rose 5.0%. Our three small-company funds shone, too: T. Rowe Price QM U.S. Small-Cap Growth (PRDSX), T. Rowe Price Small-Cap Value (PRSVX) and Wasatch Small Cap Value (WMCVX) beat the Russell 2000 small-company index.

We’re being patient with some of our foreign funds. AMG TimesSquare International Small Cap (TCMPX), Baron Emerging Markets (BEXFX) and Oakmark International (OAKIX) each trailed their benchmarks. Fidelity International Growth (FIGFX), however, beat the MSCI EAFE, albeit with a 3.2% loss.

Most of our U.S. bond funds—from high-yield to funds focused on intermediate-term maturities—kept pace with or beat the Agg index. But emerging-markets bonds had a rough year. Fidelity New Markets Income (FNMIX) lagged its benchmark, the JPMorgan Emerging Markets Bond Index.

We swap out one fund

Every garden needs reshaping every now and then. The Kiplinger 25, for instance, has grown heavy in large-company funds. In recent years, eight of the group’s 12 diversified stock funds focused on big firms. Only four were small- or midsize-company funds. That’s one of the reasons we are replacing Fidelity New Millennium (FMILX) with DF Dent Midcap Growth (DFDMX).

New Millennium struggled, too. Manager John Roth invests in fast-growing firms, but he’s sensitive to their share price. As the multiyear rally in growth stocks has worn on, Roth has grown more contrarian—for example, picking up shares in beleaguered General Electric at various times in 2018. When the fund joined the Kip 25 in May 2014, Morningstar considered New Millennium a large-growth fund. Today, it’s a large-blend fund, reflecting its mix of growth and value holdings. But New Millennium has lagged peers in both the growth and blend categories, and it lagged Standard & Poor’s 500-stock index in four of the past five calendar years.

At DF Dent Midcap Growth, four managers work as a team with seven analysts to find 30 to 40 firms that have solid, growing businesses that generate large amounts of cash, dominate a niche in their industry and have talented executives who invest wisely, with their shareholders in mind. If the share price isn’t attractive relative to a stock’s expected return, they’ll wait for the right price to buy it.

The team does detailed analysis, visiting companies on their turf and talking to customers and suppliers. When company representatives visit DF Dent’s offices, they’re asked how they got there (commercial airline or private jet). “We look for frugal firms. A company’s money is the shareholders’ capital, not their own,” says comanager Bruce Kennedy.

When the portfolio managers buy a stock, they tend to hold it. The fund’s typical holding period is three years, nearly double the holding period of the typical midsize-company fund. They’ll hold on even as some firms grow into large-cap names, such as gene-sequencing giant Illumina, as long as those companies are still fast-growing.

Over the past one, three and five years, DF Dent Midcap Growth has outpaced its benchmark, the Russell Mid Cap index, as well as its peers (funds that invest in midsize, growing companies). The firm’s five-year annualized return stands among the top 23% of its category.

Most Popular

Don’t Be Tricked Into Voluntarily Paying Higher Taxes on Your IRA
IRAs

Don’t Be Tricked Into Voluntarily Paying Higher Taxes on Your IRA

Traditional IRAs are set up in a way that basically incentivizes you (and your heirs) into paying the highest tax bill possible. Don’t fall for it. Co…
July 4, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
Retirees, Make These Midyear Moves to Cut Next Year's Tax Bill
Tax Breaks

Retirees, Make These Midyear Moves to Cut Next Year's Tax Bill

Save money next April by making these six hot-as-July tax moves.
July 1, 2022

Recommended

How to Go to Cash
investing

How to Go to Cash

What exactly does it mean to 'go to cash,' and what should you do once you have?
July 5, 2022
Is the Stock Market Closed for the Fourth of July in 2022?
Markets

Is the Stock Market Closed for the Fourth of July in 2022?

Independence Day falls on a Monday in 2022, so the bond and stock markets will enjoy a long holiday weekend. Here's a look at the markets' holiday hou…
July 1, 2022
Top Bear Market Tips from 10 Financial Advisers
investing

Top Bear Market Tips from 10 Financial Advisers

When a bull market turns into a bear market, it can be hard to know what to do. Take comfort in the guidance of 10 financial professionals.
June 30, 2022
The 15 Best Growth Stocks for the Rest of 2022
growth stocks

The 15 Best Growth Stocks for the Rest of 2022

A sharp selloff in growth stocks this year creates opportunity for keen investors. Here are 15 top-rated picks to consider in the second half of 2022.
June 28, 2022